ACG Wealth’s Organon & Co OGN Stock Holding History

ACG Wealth’s Portfolio OGN Stock Details OGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q3	–	Sell	-911	Closed	-$31K	–	768
2022 Q2	$31K	Buy	+911	New	+$31.9K	0.01%	504

Other funds holding OGN

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Mawer Investment Management Calgary, Alberta, Canada $15.4B AUM 10.9% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Lord, Abbett & Co Jersey City, New Jersey $30.6B AUM 57.44% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

ACG Wealth's OGN Position: Q3 2022 in Review

ACG Wealth sold out of Organon & Co (OGN) in Q3 2022, closing a stake of 911 shares — an estimated $31K sold.

ACG Wealth first reported a position in OGN in Q2 2022 and held it in 1 quarter. The position peaked at $31K in Q2 2022. 791 funds tracked by Wall St. Rank hold OGN as of Q3 2022.

ACG Wealth reported no remaining Organon & Co position as of Q3 2022 after selling out during the quarter.
ACG Wealth sold 911 Organon & Co shares in Q3 2022, an estimated $31K.
ACG Wealth first reported a position in Organon & Co in Q2 2022 and held it in 1 quarter.
ACG Wealth's Organon & Co position peaked at $31K in Q2 2022.
791 funds tracked by Wall St. Rank held Organon & Co as of Q3 2022.

Based on ACG Wealth's 13F filing for Q3 2022, filed 3 Nov 2022.